Illness	Number of cases
Hyperplasia of prostate (N40)	522
Malignant neoplasm of prostate (C61)	113
Unspecified haematuria (R31)	17
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	12
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	11
Obstructive and reflux uropathy - Hydronephrosis with ureteropelvic junction obstruction (N13.0)	8
Other disorders of urinary system - Incontinence without sensory awareness (N39.42)	7
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9)	6
Calculus of kidney and ureter - Calculus of ureter (N20.1)	6
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4)	5

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	724
Surgical removal or destruction of prostatic tissue through the urethra (5-601.72)	313
Surgical removal or destruction of prostatic tissue through the urethra (5-601.70)	221
Operation using lasers (5-985.8)	93
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	48
Surgical removal or destruction of prostatic tissue through the urethra (5-601.42)	48
Operation using lasers (5-985.7)	43
Surgical removal or destruction of prostatic tissue through the urethra (5-601.9)	41
Operation using a navigation system which produces real-time 3-D images of the surgical site during the operation (5-988.2)	41
Operation using a surgical robot (5-987.x)	40

Further information about the department

Out-patient accident insurance doctor approval

Yes

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
110	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
48	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
36	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Participation in multi-centre phase III/IV studies
Doctoral supervision
Lectureships / teaching posts at colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies